Auxilius Pharma S.A. · Healthcare · N/a
Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 2 other checks.
Auxilius Pharma S.A. is a small emerging pharmaceutical company specializing in cardiovascular health, particularly focusing on value-added medicines such as AUX-001, an antianginal agent designed to improve patient outcomes and reduce hospitalizations. The company targets healthcare providers, payors, and patients with cardiovascular conditions, positioning itself as an innovative player in the pharmaceutical market with a clear mission and product focus. The website reflects a professional and consistent brand image with clear business information and contact details. Technically, the website is built using modern technologies including React and Gatsby, hosted on A2 Hosting, and employs Tailwind CSS for styling. It demonstrates good performance, mobile optimization, and basic accessibility features. SEO is well addressed with proper meta tags and structured content. Google Tag Manager is used for analytics and tracking, with a cookie consent banner ensuring user privacy compliance. From a security perspective, the site uses HTTPS with good SSL configuration but lacks explicit security headers and dedicated security or incident response policies. No vulnerabilities or suspicious content were detected. Privacy compliance is well addressed with a privacy policy and cookie consent mechanism, though GDPR-specific details could be enhanced. The WHOIS data shows consistent domain registration aligned with the business founding date, no privacy protection, and registrar locks, indicating legitimacy. Overall, the website presents a low-risk profile with good business credibility and technical maturity. Strategic recommendations include implementing security headers, publishing a security policy or vulnerability disclosure, enhancing accessibility, and continuous monitoring of third-party scripts to maintain security and compliance.
Scanned
NIS2 Art. 21(2)
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
5 findings rated critical or high. Fix these first.
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
Controls resources the browser is allowed to load
What to do: Implement a Content-Security-Policy appropriate for your application
These are the privacy signals visitors and data protection authorities look for under GDPR.
GDPR requires clear information about cookie usage
What to do: Add a dedicated cookie policy explaining cookie usage and purposes
TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.
Server supports weak protocols: TLSv1.1
What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions
SSL certificate uses 256-bit key, which is considered weak
What to do: Use at least 2048-bit RSA or 256-bit ECC key
DNS sends visitors and email to the right servers. Misconfigured records can cause outages or let someone redirect your traffic.
MX record points to unregistered domain: auxiliuspharma-com.mail.protection.outlook.com
What to do: Remove or fix MX record pointing to unregistered domain
Need hands-on remediation? Email guard@offseq.com
This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
€25per month
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
€39.90one-time
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Each check with its score, findings and the evidence it collected.
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
Not counted
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Leaked records that mention auxiliuspharma.com, from OffSeq Breach.
No leaked records found
Breach holds no records for auxiliuspharma.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Automated reading of the public site. Ratings are indicative.
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Retrieved 2026-10-25
Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.
Reviews of this site
Share your experience with auxiliuspharma.com. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review auxiliuspharma.com.